Advancements in gene editing technology are boosting its adoption in various fields, including healthcare, diagnostics, agriculture, and industrial biotechnology. Clustered regularly interspaced short palindromic repeats (CRISPR), zinc-finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs) are examples of technologies that have revolutionized the gene editing field.
• The adoption of gene editing technologies is focused on therapeutics and diagnostics, with CRISPR being the most widely used technology due to the numerous advantages it offers.
• A growth driver is the rising need for precise and targeted treatment for currently incurable diseases.
• Companies are actively working to overcome the challenges associated with CRISPR technology, which has resulted in the development of novel delivery technologies, new miniaturized molecules, and nuclease expression control.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.